ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights...
New data from Part A of Phase 2b/3 trial of izokibep in Hidradenitis Suppurativa demonstrated improvements in number of draining tunnels in two-thirds of patients as early as week...